Abstract:Aim: To investigate whether transarterial chemoembolization (TACE) before liver transplantation (LT) improves long-term survival in hepatocellular carcinoma (HCC) patients. Methods: A retrospective study was conducted among 204 patients with HCC who received LT from January 2002 to December 2010 in PLA General Hospital. Among them, 88 patients received TACE before LT. Prognostic factors of serum α-fetoprotein (AFP), intraoperative blood loss, intraoperative blood transfusion, disease-free survival time, survival time with tumor, number of tumor nodules, tumor size, tumor number, presence of blood vessels and bile duct invasion, lymph node metastasis, degree of tumor differentiation, and preoperative liver function were determined in accordance with the Child-Turcotte-Pugh (Child) classification and model for end-stage liver disease. We also determined time of TACE before transplant surgery and tumor recurrence and metastasis according to different organs. Cumulative survival rate and disease-free survival rate curves were prepared using the Kaplan-Meier method, and the log-rank and χ(2) tests were used for comparisons. Results: In patients with and without TACE before LT, the 1, 3 and 5-year cumulative survival rate was 70.5% ± 4.9% vs 91.4% ± 2.6%, 53.3% ± 6.0% vs 83.1% ± 3.9%, and 46.2% ± 7.0% vs 80.8% ± 4.5%, respectively. The median survival time of patients with and without TACE was 51.857 ± 5.042 mo vs 80.930 ± 3.308 mo (χ(2) = 22.547, P < 0.001, P < 0.05). The 1, 3 and 5-year disease-free survival rates for patients with and without TACE before LT were 62.3% ± 5.2% vs 98.9% ± 3.0%, 48.7% ± 6.7% vs 82.1% ± 4.1%, and 48.7% ± 6.7% vs 82.1% ± 4.1%, respectively. The median survival time of patients with and without TACE before LT was 50.386 ± 4.901 mo vs 80.281 ± 3.216 mo (χ(2) = 22.063, P < 0.001, P < 0.05). TACE before LT can easily lead to pulmonary or distant metastasis of the primary tumor. Although there was no significant difference between the two groups, the chance of metastasis of the primary tumor in the group with TACE was significantly higher than that of the group without TACE. Conclusion: TACE pre-LT for HCC patients increased the chances of pulmonary or distant metastasis of the primary tumor, thus reducing the long-term survival rate.

Preoperative Transarterial Chemoembolization Does Not Increase Hepatic Artery Complications after Liver Transplantation: A Single Center 12-Year Experience.

Bile Duct Injury after Transcatheter Arterial Chemoembolization for Hepatic Carcinoma

Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis

Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis

Influence of Preoperative Transarterial Chemoembolization on Patients' Perioperative Safety and Short-Term Prognosis after Liver Transplantation

Influence of Preoperative Transcatheter Arterial Chemoembolization on Liver Resection in Patients with Resectable Hepatocellular Carcinoma.

Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: a Single Center Analysis.

A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.

Transarterial chemoembolization prior to liver transplantation for patients with hepatocellular carcinoma: a meta‐analysis.

[The Role of Preoperative TACE on Hepatocellular Carcinoma Located in Caudate Lobe].

Liver transplantation outcomes after transarterial chemotherapy for hepatocellular carcinoma

Influence of preoperative TACE on hepatectomy in patients with resectable large hepatocellular carcinoma

Effect of Preoperative Transcatheter Arterial Chemoembolization for Treatment of Resectable Large Hepatocellular Carcinoma:A Clinical Randomized Controlled Trial

Therapeutic Efficacy of Transcatheter Arterial Chemoembolization for Liver Cancer with High-Risk Factors

Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma

Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma

Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal

Effect of preoperative adjuvant transcatheter hepatic arterial chemoembolization on prognosis of resectable huge hepatocellular carcinoma

Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-term Survival and Recurrence in Patients with Resectable Huge Hepatocelluar Carcinoma A Multicentre Retrospective Analysis

Effect of Preoperative Chemoembolization for Resectable Hepatocellular Carcinoma with Portal Vein Invasion:A Prospective Non-Random Study

Arterial Chemoembolization Before Liver Transplantation in Patients with Hepatocellular Carcinoma: Marked Tumor Necrosis, but No Survival Benefit?